Elena Rossini | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Safety and efficacy of chronic weekly rozanolixizumab in generalized myasthenia gravis: the randomized open-label extension MG0004 study	JOURNAL OF NEUROLOGY	2025
Ravulizumab for generalized Myasthenia Gravis: a multicenter real-life experience	JOURNAL OF NEUROLOGY	2025
Complement inhibitor therapy in thymoma-associated myasthenia gravis: a real-world experience	FRONTIERS IN IMMUNOLOGY	2025
Emergent role of complement inhibitors in myasthenic crisis: Understanding why, when and how	CLINICAL NEUROLOGY AND NEUROSURGERY	2025
Role of the repeat expansion size in predicting age of onset and severity in RFC1 disease	BRAIN	2024
Muscle MRI as a biomarker of disease activity and progression in myotonic dystrophy type 1: a longitudinal study	JOURNAL OF NEUROLOGY	2024
Comparison of quantitative muscle ultrasound and whole-body muscle MRI in facioscapulohumeral muscular dystrophy type 1 patients	NEUROLOGICAL SCIENCES	2023
Quantitative sensory testing and skin biopsy findings in late‐onset ATTRv pre‐symptomatic carriers: relationships with predicted time of disease onset (PADO)	JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM	2023
Prominent mitochondrial pathology in a case of refractory dermatomyositis: coincidence or concause?	NEUROLOGICAL SCIENCES	2023
Eculizumab for myasthenic exacerbation during treatment with immune-checkpoint inhibitors	NEUROLOGICAL SCIENCES	2023
Muscle MRI in immune-mediated necrotizing myopathy (IMNM). implications for clinical management and treatment strategies	JOURNAL OF NEUROLOGY	2022
Distal upper limb involvement in myasthenia-myositis association	NEUROLOGICAL SCIENCES	2022